You are here
HARRISVACCINES, INC.
UEI: N/A
# of Employees: 20
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Next Generation Vaccine for Infectious Bovine Keratoconjuctivitis
Amount: $99,333.00Currently available vaccines for infectious bovine keratoconjunctivitis (IBK), also known as "pinkeye", have poor efficacy and low cross-protection between strains. This may be partly due to the lack ...
SBIRPhase I2014Department of Agriculture -
Replicon Particle Vaccine for White Spot Syndrome Virus in Marine Shrimp Phase II
Amount: $460,000.00Currently there are no truly effective interventions or therapeutic treatments for White spot syndrome virus (WSSV) in farmed shrimp. Current production practices focus on pathogen exclusion by stocki ...
SBIRPhase II2011Department of Agriculture -
Replicon Particle Vaccine for White Spot Syndrome Virus in Marine Shrimp
Amount: $79,700.00WSSV is the most serious disease in farmed marine shrimp causing considerable financial losses throughout the last decade across the globe. It infects a wide variety of crustacean hosts including nume ...
SBIRPhase I2010Department of Agriculture -
Demonstrate the Safety and Efficacy of a PRRS-RP Vaccine Candidate
Amount: $346,765.00Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) costs the swine industry approximately $560M annually through reproductive loss in mature females and respiratory disease in growing pigs. T ...
SBIRPhase II2009Department of Agriculture -
Autogenous replicon particle (ARP) vaccines for porcine reproductive and respiratory syndrom virus (PRRSV)
Amount: $79,920.00There is a clear and immediate need for improved PRRSV vaccines. PRRS is estimated to cost pork producers in the U.S. nearly $600 million annually and with a national eradication effort being proposed ...
SBIRPhase I2007Department of Agriculture